Bioavailability Study of 10 Milligram (mg) and 5 mg Tablets Versus Conventional Tablets of Dolutegravir

NCT03095638 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

38

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Conventional dolutegravir 10 mg tablet
DRUG: Conventional dolutegravir 50 mg tablet
DRUG: Dispersible dolutegravir 5 mg tablet
DRUG: Conventional dolutegravir 25 mg tablet

Sponsor

ViiV Healthcare

Collaborators

[object Object]